NF-κB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes

Cardiovascular Research

Volumn 85, Issue 3, 2010, Pages 473-483

  Mariappan, Nithya ^a   Elks, Carrie M ^a   Sriramula, Srinivas ^a   Guggilam, Anuradha ^a   Liu, Zhizhen ^a,b   Borkhsenious, Olga ^a   Francis, Joseph ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Free radicals; Mitochondria; NF B; Oxidative stress; Type II diabetes

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CHOLESTEROL; DITHIOCARBAMIC ACID; FREE RADICAL; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PEROXYNITRITE; PROTEIN P50; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SUPEROXIDE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UBIQUINOL CYTOCHROME C REDUCTASE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; ELECTRON SPIN RESONANCE; GENE EXPRESSION; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART WEIGHT; IMMUNOFLUORESCENCE; MALE; MITOCHONDRION SWELLING; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BLOOD; DRUG ANTAGONISM; HEART; METABOLISM; MITOCHONDRION; ORGAN SIZE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; ELECTRON TRANSPORT COMPLEX III; GLUTATHIONE; HEART; INTERLEUKIN-6; MALE; MICE; MITOCHONDRIA; NF-KAPPA B; ORGAN SIZE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 74249092946     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp305     Document Type: Article

References (44)

1. NIDDK. National Diabetes Statistics, 2007. Bethesda, MD: US Department of Health and Human Services, NIH; 2008.
2. AHA. Metabolic Syndrome Statistics Statistical Fact Sheets. Dallas, TX: American Heart Association; 2009.
3. Kelishadi R, Gharipour M, Sadri GH, Tavasoli AA, Amani A. Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population. East Mediterr Health J 2008;14:1070-1079.
4. Khan KA, Sowers JR. Surgical treatment of the cardiometabolic syndrome and obesity. J Cardiometab Syndr 2008;3:254-257.
5. Cai L, Kang YJ. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol 2001;1:181-193.
6. Lopes JP, Oliveira SM, Soares Fortunato J. Oxidative stress and its effects on insulin resistance and pancreatic beta-cells dysfunction: relationship with type 2 diabetes mellitus complications. Acta Med Port 2008;21:293-302.
7. Pop-Busui R, Sima A, Stevens M. Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev 2006;22:257-273.
8. Ziolo MT, Kohr MJ, Wang H. Nitric oxide signaling and the regulation of myocar-dial function. J Mol Cell Cardiol 2008;45:625-632.
9. Ungvari Z. Role of Oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol 2005;3: 221-229.
10. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 2003;140-141:113-124.
11. Turko IV, Murad F. Protein nitration in cardiovascular diseases. Pharmacol Rev 2002;54:619-634.
12. Hausladen A, Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 1994;269:29405-29408.
13. Sriramula S, Haque M, Majid DS, Francis J. Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 2008;51:1345-1351.
14. Kang YM, Ma Y, Elks C, Zheng JP, Yang ZM, Francis J. Cross-talk between cyto-kines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kappaB. Cardiovasc Res 2008;79:671-678.
15. Mariappan N, Soorappan RN, Haque M, Sriramula S, Francis J. TNF-alpha-induced mitochondrial oxidative stress and cardiac dysfunction: restoration by superoxide dismutase mimetic Tempol. Am J Physiol Heart Circ Physiol 2007;293: H2726-H2737.
16. Mariappan N, Elks CM, Fink B, Francis J. TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction. Free Radic Biol Med 2009;46:462-470.
17. Schreck R, Albermann K, Baeuerle PA. Nuclear factor kB: an oxidative stress-responsive transcription factor of eukaryotic cells (A review). Free Radic Res Commun 1992;17:221-237.
18. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J 1991;10:2247-2258.
19. Christman JW, Blackwell TS, Juurlink BH. Redox regulation of nuclear factor kappa B: therapeutic potential for attenuating inflammatory responses. Brain Pathol 2000;10:153-162.
20. Elks CM, Mariappan N, Haque M, Guggilam A, Majid DS, Francis J. Chronic NF-gkappagB blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR. Am J Physiol Renal Physiol 2009; 296:F298-F305.
21. Ebenezer PJ, Mariappan N, Elks CM, Haque M, Soltani Z, Reisin E et al. Effects of pyrrolidine dithiocarbamate on high-fat diet-induced metabolic and renal alterations in rats. Life Sci 2009;85:357-364.
22. Brennan P, O'Neill LA. Inhibition of nuclear factor kappaB by direct modification in whole cells\-mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem Pharmacol 1998;55:965-973.
23. Brennan P, O'Neill LA. Inhibition of NF kappa B activity by oxidative processes in intact cells mechanism of action of pyrolidine dithiocarbamate and diamide. Biochem Soc Trans 1996;24:3S.
24. Bowie A, O'Neill LAJ. Oxidative stress and nuclear factor-[kappa]B activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000;59:13-23.
25. Staal FJT, Roederer M, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor ?B and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 1990;87:9943-9947.
26. Zimmerman MC, Zucker IH. Mitochondrial dysfunction and mitochondrial-produced reactive oxygen species: new targets for neurogenic hypertension? Hypertension 2009;53:112-114.
27. Tsutsui H. Oxidative stress in heart failure: the role of mitochondria. Intern Med 2001;40:1177-1182.
28. Brownlee M. The pathobiology of diabetic complications. Diabetes 2005;54: 1615-1625.
29. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
30. Sriramula S, Haque M, Majid DSA, Francis J. Involvement of tumor necrosis factor-galphag in angiotensin ii-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 2008;51:1345-1351.
31. Khaleduzzaman M, Francis J, Corbin ME, McIlwain E, Boudreaux M, Du M et al. Infection of cardiomyocytes and induction of left ventricle dysfunction by neuro-virulent polytropic murine retrovirus. J Virol 2007;81:12307-12315.
32. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006;444:875-880.
33. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424.
34. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 2002;61:186-194.
35. Lyall F, Gibson JL, Greer IA, Brockman DE, Eis AL, Myatt L. Increased nitrotyro-sine in the diabetic placenta: evidence for oxidative stress. Diabetes Care 1998;21: 1753-1758.
36. Ceriello A, Quagliaro L, Catone B, Pascon R, Piazzola M, Bais B et al. Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 2002;25: 1439-1443.
37. Pacher P, Obrosova IG, Mabley JG, Szabo C. Role of nitrosative stress and perox-ynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 2005;12:267-275.
38. Cai L, Wang J, Li Y, Sun X, Wang L, Zhou Z et al. Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Diabetes 2005;54:1829-1837.
39. Ceriello A, Quagliaro L, D'Amico M, Di Filippo C, Marfella R, Nappo F et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 2002;51:1076-1082.
40. Chen Q, Lesnefsky EJ. Depletion of cardiolipin and cytochrome c during ischemia increases hydrogen peroxide production from the electron transport chain. Free Radic Biol Med 2006;40:976-982.
41. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790.
42. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 2000;97: 12222-12226.
43. Echtay KS, Roussel D, St-Pierre J, Jekabsons MB, Cadenas S, Stuart JA et al. Superoxide activates mitochondrial uncoupling proteins. Nature 2002;415: 96-99.
44. Ceylan-Isik AF, Wu S, Li Q, Li SY, Ren J. High-dose benfotiamine rescues cardio-myocyte contractile dysfunction in streptozotocin-induced diabetes mellitus. J Appl Physiol 2006;100:150-156.